Former Pfizer China VP Xiao Hong Deng Joins Beijing Yiming Technology as CEO to Accelerate Healthcare Digital Transformation

2020 was a year of rapid growth for Beijing Yiming Technology Co., Ltd. During this period, the company not only achieved sustained profitability but also attracted a cohort of industry leaders to join its team.

Ms. Deng Xiaohong, who has recently joined Beijing Yiming Technology Co., Ltd., previously served as Vice President of Pfizer China. She held the position of General Manager for the Cardiovascular and Neuroscience divisions, where she led a sales team of over 2,000 employees and achieved an industry milestone by generating annual revenues exceeding $1 billion. Prior to joining Yiming Technology, Ms. Deng served as the Head of Customer Strategy and Insights for Pfizer China’s Marketing Department starting in 2017. In this role, she established the industry’s first innovative digital team and developed profound expertise and insights into the digital transformation of the healthcare ecosystem. Upon joining Yiming Technology, Ms. Deng assumed the role of Chief Executive Officer, overseeing the company’s overall strategy and operations.

Joining Beijing Yiming Technology Co., Ltd. are two industry experts with clinical backgrounds and over twenty years of experience in the healthcare sector. Ms. Zhang Bin formerly served as Senior Strategy and Execution Manager at Pfizer China, where she planned and led innovative internet hospital projects in the neuropsychiatry field, offering unique insights into the construction and operation of internet hospitals. Ms. Jiang Hua was a founding member of Pfizer China’s multi-channel marketing team and is highly proficient in digital marketing.

Since joining Beijing Yiming Technology Co., Ltd., Deng Xiaohong has been extremely busy, yet she thoroughly enjoys this sense of busyness. “Medical digital intelligence is an emerging industry direction. Its appeal makes it well worth the substantial time I devote to learning and exploration.” When asked why she chose Beijing Yiming Technology Co., Ltd., Deng Xiaohong stated, “Since its establishment in 2013, Yiming Technology has built a solid technological and business foundation, achieving remarkable growth from scratch, and has implemented numerous innovative practices in the digital-intelligent transformation of healthcare that have been widely recognized by clients. Leveraging my years of experience in corporate management, I will help drive the company’s rapid scaling from 1 to N!”

Deng Xiaohong analyzed that current medical institutions generally face three major pain points: a high-cost, low-efficiency healthcare system; subpar quality of medical services; and the persistent difficulty and high expense of accessing medical care. With the continuous improvement of the top-level design for “trinity” smart hospitals, it has become imperative for hospitals to undergo digital and intelligent transformation and upgrading. This shift is essential to enhance refined and intelligent management standards and to provide better services for both physicians and patients.

Governance and insight technologies for big data are the decisive factors driving the digital and intelligent transformation of healthcare. Therefore, to overcome the development challenges faced by hospitals, it is essential to govern the massive volumes of internal data and cultivate keen insights into medical scenarios, thereby bringing data to life. Yiming Technology leverages its “Yiming Brain” and AI technologies to revitalize hospitals’ big data assets, empowering them to achieve smart healthcare, smart services, and smart management, thus accelerating the digital and intelligent transformation of the medical sector.

It is important to emphasize that the digital and intelligent transformation of healthcare encompasses every aspect of hospital operations, and the sheer “volume” of data involved speaks for itself.

Managing the vast amounts of data within hospitals requires a technical architecture equipped with advanced algorithms and computing power. The “Yiming Brain,” launched by Yiming Technology, consists of the Yiming Left Brain (Data Middle Platform) and the Yiming Right Brain (Business Middle Platform).

Yiming Left BrainHolds multiple technical patents and features a comprehensive data governance framework, supporting intelligent, high-speed, and accurate data collection, structuring, standardization, and other data governance processes;Yiming Right BrainLeveraging deep insights into the medical, healthcare, and pharmaceutical sectors, it applies professional knowledge graphs and medical logic to build disease-specific algorithms, configure functionalities, and encapsulate them into low-code products for scenario-based applications. The efficient operation of the Yiming Brain supports the production and iterative updates of Beijing Yiming Technology Co., Ltd.’s customer-centric, high-efficiency business model.

Deng Xiaohong revealed that in recent years, Beijing Yiming Technology Co., Ltd. has maintained strong growth momentum. The company achieved positive operational cash flow as early as the second quarter of 2019. By the first quarter of 2021, its order volume had already reached 94% of the full-year total for 2020, with year-on-year revenue growth of 400%.

Behind this outstanding “report card” lies a close connection to the distinctive qualities of the Yiming Technology team.

Vitality and innovation are the hallmarks of Yiming Technology’s team. It is reported that the core members of Yiming Technology’s team have many years of work experience in multinational corporations, enabling them to view changes in China’s industry and market from a global perspective and giving them unique advantages in business understanding. In addition, the company has recruited top-tier AI R&D and big data teams, medical experts, and seasoned professionals in the pharmaceutical field. As a young startup, Beijing Yiming Technology Co., Ltd. has always prioritized talent acquisition as a key component of its development strategy, given its business progress and expansion of product lines.

Beijing Yiming Technology Co., Ltd. envisions itself as an expert in medical data governance and insights, empowering hospitals with big data and AI technologies to realize the mission of “enabling good doctors to help more patients, and helping more doctors become good doctors.”